|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-2-22
|
|
pubmed:abstractText |
Previous studies on atherectomy specimens from patients with acute coronary syndrome (ACS) implicated the role of proteolytic enzymes. We examined whether the plasma levels of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) were increased in the coronary circulation in ACS.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0002-8703
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
141
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
211-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11174334-Acute Disease,
pubmed-meshheading:11174334-Adult,
pubmed-meshheading:11174334-Aged,
pubmed-meshheading:11174334-Biological Markers,
pubmed-meshheading:11174334-Coronary Circulation,
pubmed-meshheading:11174334-Coronary Disease,
pubmed-meshheading:11174334-Female,
pubmed-meshheading:11174334-Heart Catheterization,
pubmed-meshheading:11174334-Humans,
pubmed-meshheading:11174334-Male,
pubmed-meshheading:11174334-Matrix Metalloproteinase 9,
pubmed-meshheading:11174334-Middle Aged,
pubmed-meshheading:11174334-Prognosis,
pubmed-meshheading:11174334-Severity of Illness Index,
pubmed-meshheading:11174334-Syndrome,
pubmed-meshheading:11174334-Tissue Inhibitor of Metalloproteinase-1
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
|
|
pubmed:affiliation |
Second Department of Internal Medicine, Hirosaki University School of Medicine, Zaifu-cho, Hirosaki 036-8562, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
